Skip to content
Menu
Primary Navigation
Primary Navigation
Home
Psilocybin Facts
History
Albert Hofmann
Ongoing/recently completed clinical trials
Latest scientific publications
Legals aspects concerning psilocybin
Molecular Structure & Chemical Details
Neuroscience
Psilocybin as a partial agonist of the 5-HT2A receptor
Neuronal interconnectivity
Neurochemical correlates of creativity
Psilocybin and neuroplasticity
Neuropolitics
Mycelia networks, adaptogens, and mental health
Neurochemistry
Psychology
Cross-modal synesthesia
Psilocybin and creativity
Psilocybin and ego-dissolution
Psilocybin and metacognition
Psilocybin and shamanism
Psilocybin and near-death anxiety
Psilocybin as a therapeutic adjunct for PTSD
Psilocybin and visual perception
Psilocybin as a catalyst of spiritual experiences
Psilocybin & Genetic Ageing
Philosophy of Mind
Psilocybin and Qualia
Misc
Imaginal cells
Full reference list HTML
From psychotomimetic to psychedelic
GoogleTrends analysis for Psilocybin (R-code)
Page overview
Media coverage of psilocybin
Hologenome theory of evolution
Documentaries
News
Podcasts
Psilocybin Research Blog
CogNovo
John M. Allegro
MindMap (dynamic information visualization)
Lectures
Homo consumens
Philosophy
Paul H. Hoch – Experimental lobotomies and psychopathology
Chemistry
Marie-Curie actions
CIA project MK Ultra
Gordon Wasson
A Review of the Clinical Effects of Psychotomimetic Agents
Mycophilia
EU FP7
Newsletter
www.psychedelic-lab.com
Varia
RSS
Sitemap Tree